Patents
Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
07/2010
07/28/2010CN101785762A Huperzine A orally disintegrating tablets and preparation method thereof
07/27/2010US7763729 Bicyclic heteroaromatic derivatives
07/27/2010CA2436659C Cannabinoid receptor ligands
07/27/2010CA2375820C The myostatin gene promoter and inhibition of activation thereof
07/22/2010WO2010081862A2 Methods and preparations for protecting critically ill patients
07/22/2010US20100184825 for treating, preventing, inhibiting, or reducing obesity, insulin resistance, diabetes and any other disease, trait, or condition that is related to or will respond to the levels of PTP-1B in a cell or tissue
07/22/2010US20100184784 Pharmaceutical compositions comprising a multifunctional phosphodiesterase inhibitor and an adenosine uptake inhibitor
07/22/2010US20100184730 Fatty Acid Acylated Salicylates and Their Uses
07/22/2010US20100184717 Treatment of Statin Side Effects Using Uridine Derivatives
07/22/2010US20100183695 Cerberus/coco derivatives and uses thereof
07/22/2010US20100183620 Compositions and methods for regulating collagen and smooth muscle actin expression by serpine2
07/22/2010US20100183571 Treatment of multiple sclerosis using placental stem cells
07/22/2010US20100183567 Novel Mammalian Multipotent Stem Cells and Compositions, Methods of Preparation and Methods of Administration Thereof
07/21/2010CN101780226A Plaster for treating bone injury
07/21/2010CN101780198A Traditional Chinese medicine for treating spasm after paraplegia
07/21/2010CN101780124A Capparis acutifolia sweet exact and preparation method and application thereof
07/21/2010CN101780123A Peganum harmala L extract chewable tablets and preparation method thereof
07/20/2010US7759486 2,4,5-Trisubstituted pyrimidine compounds
07/20/2010US7759367 Pharmaceutical compositions and their uses
07/20/2010US7759314 Stabilizing collagen VI-deficient dystrophin-associated protein complexes (DAPCs) on the surface of a cell by contacting the cell with an effective amount of a biglycan therapeutic; treatment of muscular dystrophies
07/20/2010US7758871 Relieving spastic muscle pain; ultrasonic frequency disruption of stratum corneum and applying patch containing neurotoxin
07/15/2010WO2010081070A2 Novel forms of eperisone
07/15/2010WO2010080581A2 Valproic acid, derivatives, analogues, and compositions including same and methods for their therapeutic use
07/15/2010WO2010080455A1 New salts
07/15/2010WO2010079668A1 Olefin compound
07/15/2010US20100179212 Pharmaceutical composition which improves in vivo gene transfer
07/15/2010US20100179112 Nutritional Intervention for Improving Muscular Function and Strength
07/15/2010US20100178348 Myostatin Inhibition for Enhancing Muscle and/or Improving Muscle Function
07/15/2010US20100178280 Use of sirt7 for treating age-related diseases
07/15/2010CA2747558A1 New salts
07/14/2010EP2206772A2 Method of collecting placental stem cells
07/14/2010EP2206720A1 Albumin fusion proteins
07/14/2010EP2206511A1 Protein a compositions and methods of use
07/14/2010CN101778636A Use of 25-hydroxy vitamin d3 to increase muscle mass in mammals
07/14/2010CN101773650A Chinese medicinal composition for treating clonic convulsion and preparation method thereof
07/13/2010US7756643 Method for determining the biological effect and/or activity of at least one drug, chemical substances and/or pharmaceutical composition based on their effect on the methylation status of DNA
07/13/2010US7754735 such as 3-(2-chloro-4-quinolinyl)-2,5-dimethyl-1H-indole-1-acetic acid, used for treating respiratory system disorders and as inhibitors of G protein-coupled receptor chemoattractant homologous receptor expressed on lymphocyte cells (CRTH2)
07/13/2010CA2446820C Novel pyrrole derivatives as pharmaceutical agents
07/13/2010CA2446463C Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
07/13/2010CA2430539C Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
07/13/2010CA2372443C Local administration of anti-malarial agents for the treatment of inflammatory diseases
07/08/2010WO2010077686A1 Isoindolinone and related analogs as sirtuin modulators
07/08/2010WO2010075611A1 Composition comprising proanthocyanidin, proteolytic enzyme and aloe vera/agave species substance
07/08/2010WO2010039823A3 Compositions and methods for tissue repair with extracellular matrices
07/08/2010US20100174076 Coumarin derivatives useful as tnf alpha inhibitors
07/08/2010US20100173997 2,4,6-trisubstituted phenols having anesthetic properties
07/08/2010US20100173983 Method for inducing autophagy
07/08/2010US20100173930 Certain Chemical Entities, Compositions and Methods
07/08/2010US20100173841 Highly Purified Type A Botulinum Toxin Preparation From Infant Botulism Pathogen
07/08/2010US20100173826 Smooth Muscle Relaxation
07/08/2010US20100172940 Treatment of soft tissue injury using hyaluronic acid and botulinum toxin
07/08/2010CA2746221A1 Isoindolinone and related analogs as sirtuin modulators
07/07/2010EP2204172A1 Agent having neurotrophic factor-like activity
07/07/2010EP2203173A2 Means and methods for counteracting muscle disorders
07/07/2010EP1900811B1 Enriched central nervous system cell populations
07/07/2010EP1485099B1 Inhibitors of histone deacetylase
07/07/2010CN1859918B Use of hyaluronic acid for treating acute and overuse sprain and strain
07/07/2010CN101766746A External bee venom liniment
07/06/2010US7750016 Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones
07/06/2010US7750011 Diazabicyclic aryl derivatives and their medical use
07/06/2010US7749735 Interferon receptor variant for treatment and prevention of cell proliferative, autoimmune and viral diseases; prolonged activation of interferon beta
07/06/2010US7749514 Activatable clostridial toxins
07/06/2010CA2461199C Atlastin
07/06/2010CA2454863C Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
07/01/2010WO2010075287A2 Compounds and methods for the treatment of pain and other diseases
07/01/2010WO2010075263A2 Compounds and methods for enhancing erythropoiesis
07/01/2010WO2010074284A1 Pyrazolopyrimidine compound
07/01/2010WO2010073531A1 Muscle-building agent
07/01/2010US20100169989 Use of Follistatin-Like Related Gene (FLRG) to Increase Muscle Mass
07/01/2010US20100168239 Use of Rasagiline for the Treatment of Multiple System Atrophy
07/01/2010US20100168099 1h-quinolin-4-one compounds, with affinity for the gaba receptor, processes, uses and compositions
07/01/2010US20100168040 Muscle fatigue remedy
07/01/2010US20100168023 Injectable Botulinum Toxin Formulations
07/01/2010US20100168020 Stabilized receptor polypeptides and uses thereof
07/01/2010US20100166856 Pharmaceutical composition in the form of coated microspheres for the modified release of a muscle relaxant and an nsaid
07/01/2010US20100166764 Anti-myostatin antibodies
07/01/2010US20100166757 Antibodies against monocyte chemotactic proteins
07/01/2010US20100166733 Mcp-1 splice variants and methods of using same
07/01/2010CA2747996A1 Compounds and methods for enhancing erythropoiesis
07/01/2010CA2747957A1 Compounds and methods for the treatment of pain and other diseases
06/2010
06/30/2010EP2202240A1 Compound
06/30/2010EP1330436B1 N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr3-3 receptor antagonists
06/30/2010CN1533276B Use of thiazole derivatives for preparing medicine for protecting mitochondria
06/30/2010CN101765442A organic compounds
06/30/2010CN101757458A Traditional Chinese preparation for treating facial nerve spasm
06/30/2010CN101757397A Traditional Chinese medicine for treating muscle strain
06/30/2010CN101757342A Externally-applied and orally-taken traditional Chinese medicine for treating muscle strain
06/30/2010CN101757325A Medicament waistband for treating chronic lumbar strain
06/30/2010CN101757126A Chinese medicine prescription for regulating muscle strain
06/29/2010US7745406 Kit which determines concentration of phosphate metabolizing protein and utilizes profile as indicator of hypo/hyperphosphatemic disorders
06/29/2010CA2382885C Rhodamine derivatives for photodynamic diagnosis and treatment
06/24/2010WO2010071794A1 New polymorphic form of 1- (4- { l- [ (e) -4-cyclohexyl--3-trifluoromethyl-benzyloxyimino] -ethyl) -2-ethyl-benzy l) -azetidine-3-carboxylic
06/24/2010WO2010070094A1 Myostatin binding proteins
06/24/2010WO2010069949A1 Oxadiazole fused heterocyclic derivatives useful for the treatment of multiple sclerosis
06/24/2010WO2010069684A1 Compounds for treatment of duchenne muscular dystrophy
06/24/2010US20100160400 Treatment using dantrolene
06/24/2010US20100160316 Quinazolines useful as modulators of ion channels
06/24/2010US20100160269 Use of N-(dibenz(B,F)oxepin-10-ylmethyl)-N-methyl-N-prop-2-ynylamine or a pharmaceutically acceptable addition salt thereof for the prophylaxis and/or treatment of muscular dystrophy
06/24/2010US20100160225 Lefty, lefty derivatives and uses thereof
06/24/2010US20100158982 Sheet for guiding regeneration of mesenchymal tissue and production method thereof
1 ... 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... 233